Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Jeremy Luban
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Chemicals & Drugs
Physiology
Concepts & Ideas
Genes & Molecular Sequences
Anatomy
Sign-in to see full Profile
Network (preview)
10
Goff, Stephen
9
Berthoux, Lionel
9
Braaten, Douglas
9
Sokolskaja, Elena
7
Cimarelli, Andrea
7
Colgan, John
7
Sebastian, Sarah
4
Asmal, Mohammed
4
Sayah, David
4
Gurer, Cagan
3
Höglund, Stefan
3
Yu, Bin
2
Towers, Greg
2
Strebel, Klaus
2
Lee, Youngnam
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Jeremy Luban (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Strebel Klaus; Luban Jeremy; Jeang Kuan-Teh
Human cellular restriction factors that target HIV-1 replication.
BMC medicine 2009;7():48.
-
2007: Takeuchi Hiroaki; Buckler-White Alicia; Goila-Gaur Ritu; Miyagi Eri; Khan Mohammad A; Opi Sandrine; Kao Sandra; Sokolskaja Elena; Pertel Thomas; Luban Jeremy; Strebel Klaus
Vif counteracts a cyclophilin A-imposed inhibition of simian immunodeficiency viruses in human cells.
Journal of virology 2007;81(15):8080-90.
-
2007: Berthoux Lionel; Sebastian Sarah; Muesing Mark A; Luban Jeremy
The role of lysine 186 in HIV-1 integrase multimerization.
Virology 2007;364(1):227-36.
-
2006: Zhang Shangming; Joseph Guiandre; Pollok Karen; Berthoux Lionel; Sastry Lakshmi; Luban Jeremy; Cornetta Kenneth
G2 cell cycle arrest and cyclophilin A in lentiviral gene transfer.
Molecular therapy : the journal of the American Society of Gene Therapy 2006;14(4):546-54.
-
2006: Sokolskaja Elena; Luban Jeremy
Cyclophilin, TRIM5, and innate immunity to HIV-1.
Current opinion in microbiology 2006;9(4):404-8.
-
2006: Sokolskaja Elena; Berthoux Lionel; Luban Jeremy
Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells.
Journal of virology 2006;80(6):2855-62.
-
2006: Sebastian Sarah; Sokolskaja Elena; Luban Jeremy
Arsenic counteracts human immunodeficiency virus type 1 restriction by various TRIM5 orthologues in a cell type-dependent manner.
Journal of virology 2006;80(4):2051-4.
-
2005: Berthoux Lionel; Sebastian Sarah; Sokolskaja Elena; Luban Jeremy
Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cells.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(41):14849-53.
-
2005: Bisikirska Brygida; Colgan John; Luban Jeremy; Bluestone Jeffrey A; Herold Kevan C
TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs.
The Journal of clinical investigation 2005;115(10):2904-13.
-
2005: Berthoux Lionel; Sebastian Sarah; Sayah David M; Luban Jeremy
Disruption of human TRIM5alpha antiviral activity by nonhuman primate orthologues.
Journal of virology 2005;79(12):7883-8.
-
2005: Colgan John; Asmal Mohammed; Yu Bin; Luban Jeremy
Cyclophilin A-deficient mice are resistant to immunosuppression by cyclosporine.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(10):6030-8.
-
2005: Gurer Cagan; Höglund Anders; Höglund Stefan; Luban Jeremy
ATPgammaS disrupts human immunodeficiency virus type 1 virion core integrity.
Journal of virology 2005;79(9):5557-67.
-
2005: Gurer Cagan; Berthoux Lionel; Luban Jeremy
Covalent modification of human immunodeficiency virus type 1 p6 by SUMO-1.
Journal of virology 2005;79(2):910-7.
-
2005: Sebastian Sarah; Luban Jeremy
TRIM5alpha selectively binds a restriction-sensitive retroviral capsid.
Retrovirology 2005;2():40.
-
2004: Sokolskaja Elena; Sayah David M; Luban Jeremy
Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity.
Journal of virology 2004;78(23):12800-8.
-
2004: Sayah David M; Luban Jeremy
Selection for loss of Ref1 activity in human cells releases human immunodeficiency virus type 1 from cyclophilin A dependence during infection.
Journal of virology 2004;78(21):12066-70.
-
2004: Berthoux Lionel; Sebastian Sarah; Sokolskaja Elena; Luban Jeremy
Lv1 inhibition of human immunodeficiency virus type 1 is counteracted by factors that stimulate synthesis or nuclear translocation of viral cDNA.
Journal of virology 2004;78(21):11739-50.
-
2004: Colgan John; Asmal Mohammed; Neagu Martha; Yu Bin; Schneidkraut Jason; Lee Youngnam; Sokolskaja Elena; Andreotti Amy; Luban Jeremy
Cyclophilin A regulates TCR signal strength in CD4+ T cells via a proline-directed conformational switch in Itk.
Immunity 2004;21(2):189-201.
-
2004: Sayah David M; Sokolskaja Elena; Berthoux Lionel; Luban Jeremy
Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1.
Nature 2004;430(6999):569-73.
-
2004: Chen Yali; Yan Shirley ShiDu; Colgan John; Zhang Hui-Ping; Luban Jeremy; Schmidt Ann Marie; Stern David; Herold Kevan C
Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(2):1399-405.
-
2004: Chang Fred; Re Fabio; Sebastian Sarah; Sazer Shelley; Luban Jeremy
HIV-1 Vpr induces defects in mitosis, cytokinesis, nuclear structure, and centrosomes.
Molecular biology of the cell 2004;15(4):1793-801.
-
2003: Asmal Mohammed; Colgan John; Naef Felix; Yu Bin; Lee Youngnam; Magnasco Marcelo; Luban Jeremy
Production of ribosome components in effector CD4+ T cells is accelerated by TCR stimulation and coordinated by ERK-MAPK.
Immunity 2003;19(4):535-48.
-
2003: Towers Greg J; Hatziioannou Theodora; Cowan Simone; Goff Stephen P; Luban Jeremy; Bieniasz Paul D
Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors.
Nature medicine 2003;9(9):1138-43.
-
2003: Berthoux Lionel; Towers Greg J; Gurer Cagan; Salomoni Paolo; Pandolfi Pier Paolo; Luban Jeremy
As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activity.
Journal of virology 2003;77(5):3167-80.
-
2002: Ansari Husam; Greco Giampaolo; Luban Jeremy
Cyclophilin A peptidyl-prolyl isomerase activity promotes ZPR1 nuclear export.
Molecular and cellular biology 2002;22(20):6993-7003.
-
2002: Zhang Yi-Jun; Hatziioannou Theodora; Zang Trinity; Braaten Douglas; Luban Jeremy; Goff Stephen P; Bieniasz Paul D
Envelope-dependent, cyclophilin-independent effects of glycosaminoglycans on human immunodeficiency virus type 1 attachment and infection.
Journal of virology 2002;76(12):6332-43.
-
2002: Gurer Cagan; Cimarelli Andrea; Luban Jeremy
Specific incorporation of heat shock protein 70 family members into primate lentiviral virions.
Journal of virology 2002;76(9):4666-70.
-
2001: Cimarelli A; Luban J
Context-dependent phenotype of a human immunodeficiency virus type 1 nucleocapsid mutation.
Journal of virology 2001;75(15):7193-7.
-
2001: Braaten D; Luban J
Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells.
The EMBO journal 2001;20(6):1300-9.
-
2000: Colgan J; Asmal M; Luban J
Isolation, characterization and targeted disruption of mouse ppia: cyclophilin A is not essential for mammalian cell viability.
Genomics 2000;68(2):167-78.
-
2000: Cimarelli A; Luban J
Human immunodeficiency virus type 1 virion density is not determined by nucleocapsid basic residues.
Journal of virology 2000;74(15):6734-40.
-
2000: Cimarelli A; Sandin S; Höglund S; Luban J
Rescue of multiple viral functions by a second-site suppressor of a human immunodeficiency virus type 1 nucleocapsid mutation.
Journal of virology 2000;74(9):4273-83.
-
2000: Cimarelli A; Sandin S; Höglund S; Luban J
Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA.
Journal of virology 2000;74(7):3046-57.
-
1999: Burniston M T; Cimarelli A; Colgan J; Curtis S P; Luban J
Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein.
Journal of virology 1999;73(10):8527-40.
-
1999: Cimarelli A; Luban J
Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein.
Journal of virology 1999;73(7):5388-401.
-
1998: Yin L; Braaten D; Luban J
Human immunodeficiency virus type 1 replication is modulated by host cyclophilin A expression levels.
Journal of virology 1998;72(8):6430-6.
-
1998: Yin L; Boussard S; Allan J; Luban J
The HIV type 1 replication block in nonhuman primates is not explained by differences in cyclophilin A primary structure.
AIDS research and human retroviruses 1998;14(1):95-7.
-
1997: Braaten D; Ansari H; Luban J
The hydrophobic pocket of cyclophilin is the binding site for the human immunodeficiency virus type 1 Gag polyprotein.
Journal of virology 1997;71(3):2107-13.
-
1997: Re F; Luban J
HIV-1 Vpr: G2 cell cycle arrest, macrophages and nuclear transport.
Progress in cell cycle research 1997;3():21-7.
-
1996: Luban J
Absconding with the chaperone: essential cyclophilin-Gag interaction in HIV-1 virions.
Cell 1996;87(7):1157-9.
-
1996: Franke E K; Luban J
Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction.
Virology 1996;222(1):279-82.
-
1996: Braaten D; Aberham C; Franke E K; Yin L; Phares W; Luban J
Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A.
Journal of virology 1996;70(8):5170-6.
-
1996: Colgan J; Yuan H E; Franke E K; Luban J
Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization.
Journal of virology 1996;70(7):4299-310.
-
1996: Braaten D; Franke E K; Luban J
Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses.
Journal of virology 1996;70(7):4220-7.
-
1996: Braaten D; Franke E K; Luban J
Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription.
Journal of virology 1996;70(6):3551-60.
-
1996: Braaten D; Wellington S; Warburton D; Luban J
Assignment of cyclophilin A (PPIA) to human chromosome band 7p13by in situ hybridization.
Cytogenetics and cell genetics 1996;74(4):262.
-
1995: Re F; Braaten D; Franke E K; Luban J
Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B.
Journal of virology 1995;69(11):6859-64.
-
1995: Franke E K; Chen B X; Tatsis I; Diamanduros A; Erlanger B F; Luban J
Cyclophilin binding to the human immunodeficiency virus type 1 Gag polyprotein is mimicked by an anti-cyclosporine antibody.
Journal of virology 1995;69(9):5821-3.
-
1995: Luban J; Goff S P
The yeast two-hybrid system for studying protein-protein interactions.
Current opinion in biotechnology 1995;6(1):59-64.
-
1995: Reicin A S; Paik S; Berkowitz R D; Luban J; Lowy I; Goff S P
Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity.
Journal of virology 1995;69(2):642-50.
-
1995: Franke E K; Luban J
Cyclophilin and gag in HIV-1 replication and pathogenesis.
Advances in experimental medicine and biology 1995;374():217-28.
-
1994: Franke E K; Yuan H E; Luban J
Specific incorporation of cyclophilin A into HIV-1 virions.
Nature 1994;372(6504):359-62.
-
1994: Franke E K; Yuan H E; Bossolt K L; Goff S P; Luban J
Specificity and sequence requirements for interactions between various retroviral Gag proteins.
Journal of virology 1994;68(8):5300-5.
-
1994: Luban J; Goff S P
Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA.
Journal of virology 1994;68(6):3784-93.
-
1993: Berkowitz R D; Luban J; Goff S P
Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays.
Journal of virology 1993;67(12):7190-200.
-
1993: Luban J; Bossolt K L; Franke E K; Kalpana G V; Goff S P
Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B.
Cell 1993;73(6):1067-78.
-
1993: Luban J; Lee C; Goff S P
Effect of linker insertion mutations in the human immunodeficiency virus type 1 gag gene on activation of viral protease expressed in bacteria.
Journal of virology 1993;67(6):3630-4.
-
1992: Luban J; Alin K B; Bossolt K L; Humaran T; Goff S P
Genetic assay for multimerization of retroviral gag polyproteins.
Journal of virology 1992;66(8):5157-60.
-
1991: Luban J; Goff S P
Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 gag polyprotein.
Journal of virology 1991;65(6):3203-12.
Sign-in to see more
